ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
European CHMP Adopts Positive Opinion for HEPLISAV-B
January 05, 2021Dynavax Technologies announced the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on the company's Marketing Authorization Application, recommending the granting of marketing ... -
European CHMP adopts positive opinion for Dynavax’s HEPLISAV-B vaccine for Hepatitis B
December 15, 2020Dynavax Technologies announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on the company's Marketing Authorization Application, recommending the granting of marketing ... -
Dynavax Announces FDA Advisory Committee Vote in Favor of Heplisav-B
August 01, 2017Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 12 to 1 that the safety data for Heplisav-B...
Pharma Sources Insight January 2025
